PI+ CD3+ T cells decrease at day 14 after IR while PI+ CD3- cells decrease at all time points. by Jordan A. Gunning (18143970)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

Decrease in equilibrium population size (<i>K</i>) for vole with repeated perturbations (mean ±1 SE). by Jacob Nabe-Nielsen (254477)

Ablation of Tph1 gene in dams decreased circulating serotonin and calcium on day 1 and 10 of lactation. by Jimena Laporta (383836)

Decreased IL-10 mRNA transcripts in lung CD4+ T cells correlate with worsening emphysema. by Christine M. Freeman (229357)

Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to halofantrine (HFN) and related antimalarials. by Daria Van Tyne (168938)

“…Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to (A) HFN and structurally related (B) mefloquine (MFQ) and (C) lumefantrine (LUM). …”

Inability of macrophages to respond to IL-10 results in decreased persistence of <i>B. abortus in vivo</i>. by Mariana N. Xavier (133803)

Comparison of ∑PBB, ∑BDE, ∑PCN and ∑DDT concentrations and concentrations of some congeners in eggs analyzed in this study and other relevant studies (ng/g ww, geometric mean and r... by Matti Viluksela (321291)

TGFβ1 and COL1A1 expression was decreased and RASAL1 expression was increased by Western blotting in NTM cells under both normoxic and hypoxic conditions. by Fiona McDonnell (2636635)

“…NTM cells were treated with 0.3μM 5-aza for 24 hours and then subjected to 1%O₂ for the last 6 hours of treatment. We found that COL1A1 protein was decreased in the presence of 5-aza. …”

Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

“…</p> <h3>Methods</h3><p>We completed a phase 2 multicenter trial to evaluate the efficacy and tolerability of the mTOR inhibitor, sirolimus, for the treatment of kidney angiomyolipomas.…”

A Two-Year Randomized Trial of Interventions to Decrease Stress Hormone Vasopressin Production in Patients with Meniere’s Disease—A Pilot Study by Tadashi Kitahara (702040)

“…Because mental/physical stress and subsequent increase in the stress hormone vasopressin supposedly trigger Meniere's disease, we set a pilot study to seek new therapeutic interventions, namely management of vasopressin secretion, to treat this disease. …”

Decrease of cell viability and alterations of cell membrane permeability by infection with rotavirus isolates. by Carlos A. Guerrero (1264551)

DataSheet1_Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.docx by Liang Zheng (206933)

Glycine is able to induce both a motility speed in- and decrease during zebrafish neuronal migration by Ulrike Theisen (4734555)

Production of semaphorin-7A in the NIH3T3 fibroblast cell line decreases expression of periostin and fibronectin. by Stephane Esnault (24104)

Temperature anomalies and mean annual precipitation. by Giovanna Battipaglia (711570)

Choroidal Neovascularization Is Inhibited in Splenic-Denervated or Splenectomized Mice with a Concomitant Decrease in Intraocular Macrophage by Xue Tan (2994324)

Decreased NR1 and NR2A protein expression in 21-day group. by Chenxia Han (4020017)

Image_3_A decrease in Fkbp52 alters autophagosome maturation and A152T-tau clearance in vivo.TIF by Emilie Lesport (19214344)

“…<p>The failure of the autophagy-lysosomal pathway to clear the pathogenic forms of Tau exacerbates the pathogenesis of tauopathies. We have previously shown that the immunophilin FKBP52 interacts both physically and functionally with Tau, and that a decrease in FKBP52 protein levels is associated with Tau deposition in affected human brains. …”

Table_1_A decrease in Fkbp52 alters autophagosome maturation and A152T-tau clearance in vivo.DOCX by Emilie Lesport (19214344)

“…<p>The failure of the autophagy-lysosomal pathway to clear the pathogenic forms of Tau exacerbates the pathogenesis of tauopathies. We have previously shown that the immunophilin FKBP52 interacts both physically and functionally with Tau, and that a decrease in FKBP52 protein levels is associated with Tau deposition in affected human brains. …”